Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Deferred Tax Liability (2023 - 2025)

Ascendis Pharma A's Non-Current Deferred Tax Liability history spans 1 years, with the latest figure at $6.3 million for Q4 2023.

  • For Q4 2023, Non-Current Deferred Tax Liability changed N/A year-over-year to $6.3 million; the TTM value through Dec 2023 reached $6.3 million, changed N/A, while the annual FY2023 figure was $6.3 million, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2023 was $6.3 million at Ascendis Pharma A.
  • Across five years, Non-Current Deferred Tax Liability topped out at $6.3 million in Q4 2023 and bottomed at $6.3 million in Q4 2023.